Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinghao Sun

Showing results (261-270 of 288) with videos related to

Pageof 29
Sort By:
Cell Reports|April 13, 2016
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate CancerYu Zhao, Liguo Wang, Shancheng Ren, et al.
Scientific Reports|July 5, 2017
Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progressionYang Chen, Qin Zhang, Qiuyan Wang, et al.
Asian Journal of Urology|December 22, 2017
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer ConsortiumRui Chen, Liping Xie, Xiaobing Cai, et al.
Nature Communications|October 8, 2015
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancerMeilin Wang, Atsushi Takahashi, Fang Liu, et al.
Developmental Cell|January 1, 2019
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer ProgressionJinfang Zhang, Ming Chen, Yasheng Zhu, et al.
Chinese Medical Journal|January 21, 2014
Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptomsMing Liu, Jianye Wang, Yong Yang, et al.
Urologic Oncology|May 27, 2015
Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcomeYasheng Zhu, Shancheng Ren, Taile Jing, et al.
Molecular Cell|September 8, 2015
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome DegradationJian An, Shancheng Ren, Stephen J Murphy, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Cell Research|February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsShancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
Pageof 29

Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
Cell Reports|April 13, 2016
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate CancerYu Zhao, Liguo Wang, Shancheng Ren, et al.
Scientific Reports|July 5, 2017
Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progressionYang Chen, Qin Zhang, Qiuyan Wang, et al.
Asian Journal of Urology|December 22, 2017
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer ConsortiumRui Chen, Liping Xie, Xiaobing Cai, et al.
Nature Communications|October 8, 2015
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancerMeilin Wang, Atsushi Takahashi, Fang Liu, et al.
Developmental Cell|January 1, 2019
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer ProgressionJinfang Zhang, Ming Chen, Yasheng Zhu, et al.
Chinese Medical Journal|January 21, 2014
Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptomsMing Liu, Jianye Wang, Yong Yang, et al.
Urologic Oncology|May 27, 2015
Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcomeYasheng Zhu, Shancheng Ren, Taile Jing, et al.
Molecular Cell|September 8, 2015
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome DegradationJian An, Shancheng Ren, Stephen J Murphy, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Cell Research|February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsShancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
Pageof 29